In Young C.

In Young C. has over a decade of experience in the pharmaceutical and biotechnology industry. In 2007, they joined Corestem Inc as an Associate Director and remained in that position until April 2018. In June 2018, they transitioned to Amyloid Solution Inc. as a Principal Research Scientist for a brief period. In December 2018, they moved to SL BIGEN, Inc. as an Associate Director and stayed there until October 2020. In February 2021, they returned to Amyloid Solution Inc. as the Director, Head of clinical development group. Currently, they hold the position of Director, Head of Development Group at Amyloid Solution Inc., starting from March 2023.

In Young C. earned a Master's degree in AgBiotech from Seoul National University, which was awarded from 2002 to 2004. Following this, they pursued a Ph.D course at Seoul National University of Science and Technology from 2008 to 2017, without specifying a specific field of study. Additionally, In Young C. studied AgBiology at Chungnam National University, although the start and end years are not provided.